The company is formerly known as Shanghai Jinshida Weining software Co., LTD established on April 7, 2004. The company is mainly engaged in the research and development, sales and technical services of medical health field application software, supporting hardware sales and technical service as the auxiliary. Since its establishment, the company has focused on the application of the medical industry software R&D and service in the industry. The THIS product has become a gold-lettered signboard in the industry. At present all kinds of hospital users all over the world, it is the biggest health information technology software provider in Shanghai, is also one of the most domestic energy and strength of medical software developers.
Basic Information
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
8.17%
Purchase this report to view the information.
4.93%
Purchase this report to view the information.
4.92%
Purchase this report to view the information.
4.8%
Purchase this report to view the information.
2.92%
Subsidiaries
Anhui Weining Health Technology Co., Ltd.
Beijing Huaxin Chengda Technology Co., Ltd.
Beijing Mengtianmen Technology Co., Ltd.
Company Performance
Financial values in the chart are available after Winning Health Technology Group Co.,Ltd. report is purchased.
Looking for more than just a company report?
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total operating revenue
-1.65%▼
Operating profit (EBIT)
74.39%▲
Net Profit (Loss) for the Period
24.08%▲
Operating Profit Margin (ROS)
2.75%▲
Return on Equity (ROE)
0.25%▲
Debt to Equity Ratio
-1.6%▼
